| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Neil Caporaso | |
| Mark H Greene | |||
| Christine M Mueller | |||
| P2860 | cites work | CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer | Q24318511 |
| Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q24618618 | ||
| An updated review of the literature: risk factors for bladder cancer with focus on occupational exposures | Q24718163 | ||
| Roles of FGF receptors in mammalian development and congenital diseases | Q28241041 | ||
| Germline mutations in HRAS proto-oncogene cause Costello syndrome | Q28272971 | ||
| Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms | Q33833591 | ||
| The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies | Q33912702 | ||
| Tobacco carcinogens, their biomarkers and tobacco-induced cancer | Q33973290 | ||
| Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. | Q34399048 | ||
| Lifetime risks of common cancers among retinoblastoma survivors | Q34546040 | ||
| NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses | Q34603354 | ||
| Costello syndrome: an overview | Q35057638 | ||
| Germline Translocation t(5;20)(p15;q11) and Familial Transitional Cell Carcinoma | Q57307336 | ||
| Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers | Q57559721 | ||
| Familial bladder cancer in the National Swedish Family Cancer Database | Q57568617 | ||
| Metabolic oxidation phenotypes as markers for susceptibility to lung cancer | Q59082319 | ||
| Systematic Population-Based Assessment of Cancer Risk in First-Degree Relatives of Cancer Probands | Q59548851 | ||
| Familial urinary bladder cancer | Q66933595 | ||
| Familial aggregation of bladder cancer stratified by smoking status | Q68030899 | ||
| Life style and occupational risk factors for bladder cancer in Germany. A case-control study | Q68078365 | ||
| Familial profile of transitional cell carcinoma | Q68230133 | ||
| Familial transitional cell carcinoma of renal pelvis and upper ureter | Q69501993 | ||
| Environmental exposure and bladder cancer in young males | Q69554973 | ||
| Familial aggregation of urothelial carcinoma | Q70263341 | ||
| Familial transitional cell carcinoma and the Lynch syndrome II | Q70486024 | ||
| Excess of cancer deaths in close relatives of patients with bilateral retinoblastoma | Q70656177 | ||
| Germline translocation t(5;20)(p15;q11) and familial transitional cell carcinoma | Q70956520 | ||
| Variability in caffeine metabolism | Q71244234 | ||
| Genitourinary tumors in men with the Muir-Torre syndrome | Q71826641 | ||
| Familial carcinoma of ureters and other genitourinary organs | Q71834118 | ||
| Urinary system tumours in a family | Q72248027 | ||
| Familial occurrence of carcinoma of the ureter | Q72811015 | ||
| Mutagen sensitivity in patients with familial and non-familial urothelial cell carcinoma | Q73131446 | ||
| Testing guidelines for hereditary non-polyposis colorectal cancer | Q76325357 | ||
| Multifocal transitional cell carcinoma in a patient with hereditary nonpolyposis colon cancer | Q78967114 | ||
| Bladder cancer risk as modified by family history and smoking | Q79918681 | ||
| Telomere length, cigarette smoking, and bladder cancer risk in men and women | Q80117490 | ||
| Genetic association with bladder cancer | Q93484795 | ||
| Familial and environmental interactions in bladder cancer risk | Q93575245 | ||
| N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark | Q35133059 | ||
| Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide | Q35553364 | ||
| Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies | Q35616540 | ||
| Second primary neoplasms in patients with retinoblastoma | Q36027090 | ||
| Genetic and epigenetic aspects of bladder cancer | Q36067118 | ||
| Tumor predisposition in Costello syndrome | Q36190676 | ||
| Urothelial tumorigenesis: a tale of divergent pathways | Q36234720 | ||
| Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19. | Q36356462 | ||
| Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications | Q36396727 | ||
| Non-ocular cancer in relatives of retinoblastoma patients | Q36467625 | ||
| Muir-Torre syndrome: Diagnostic and screening guidelines | Q36620719 | ||
| Scanning the horizon: what is the future of genome-wide association studies in accelerating discoveries in cancer etiology and prevention? | Q36794423 | ||
| Familial transitional cell carcinoma among the population of Iceland | Q38504879 | ||
| Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program | Q40251202 | ||
| The procarcinogen hypothesis for bladder cancer: activities of individual drug metabolizing enzymes as risk factors | Q40426603 | ||
| A New Familial Cancer Syndrome? A Spectrum of Malignant and Benign Tumors Including Retinoblastoma, Carcinoma of the Bladder and Other Genitourinary Tumors, Thyroid Adenoma, and a Probable Case of Multifocal Osteosarcoma2 | Q40475020 | ||
| Familial aggregation of urothelial cell carcinoma | Q40658599 | ||
| Familial Factors in Bladder Carcinoma | Q41028739 | ||
| A protocol for the safe administration of debrisoquine in biochemical epidemiologic research protocols for hospitalized patients | Q41187627 | ||
| Familial bladder cancer in an oncology clinic | Q41456813 | ||
| Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors | Q41463151 | ||
| Genetic predisposition and cyclophosphamide treatment in a girl with bladder carcinoma? | Q42278427 | ||
| A simple test for acetylator phenotype using caffeine | Q42532035 | ||
| Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? | Q42628372 | ||
| Genetic instability in bladder cancer assessed by the comet assay. | Q44387503 | ||
| Abnormal tryptophan metabolism in a family with a history of bladder cancer | Q44663229 | ||
| Bladder cancer in young women | Q44934858 | ||
| Nonocular second primary tumors after retinoblastoma: retrospective study of 111 patients treated by electron beam radiotherapy with or without TEM. | Q45004260 | ||
| Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer | Q45299358 | ||
| The Lynch syndrome II and urological malignancies. | Q45910851 | ||
| Metabolic gene polymorphism frequencies in control populations | Q46857953 | ||
| Familial Transitional Cell Carcinoma of the Bladder | Q46975902 | ||
| Non-ocular cancer in patients with hereditary retinoblastoma and their relatives | Q47688822 | ||
| Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994. | Q48944009 | ||
| Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options. | Q50873930 | ||
| Gardner syndrome in a man with an interstitial deletion of 5q. | Q52077264 | ||
| CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour. | Q52278234 | ||
| Sporadic bilateral retinoblastoma and 13q- chromosomal deletion | Q52310601 | ||
| Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. | Q53489724 | ||
| Genetically determined debrisoquine oxidation capacity in bladder cancer. | Q53550386 | ||
| Retinoblastoma associated with other primary malignant tumours | Q53717294 | ||
| Telomere dysfunction: a potential cancer predisposition factor. | Q55036777 | ||
| Early-onset low-grade papillary carcinoma of the bladder associated with Apert syndrome and a germline FGFR2 mutation (Pro253Arg) | Q56334119 | ||
| No Evidence For Large-scale Germline Genomic Aberrations in Hereditary Bladder Cancer Patients with High-Resolution Array-Based Comparative Genomic Hybridization | Q57307251 | ||
| Segregation analysis of urothelial cell carcinoma | Q57307262 | ||
| CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas | Q57307265 | ||
| Absence of karyotype abnormalities in patients with familial urothelial cell carcinoma | Q57307294 | ||
| Familial Transitional Cell Carcinoma Among the Population of Iceland | Q57307329 | ||
| P433 | issue | 5 | |
| P921 | main subject | transitional cell carcinoma | Q2501186 |
| P304 | page(s) | 451-464 | |
| P577 | publication date | 2008-06-18 | |
| P1433 | published in | Urologic Oncology | Q2113446 |
| P1476 | title | Familial and genetic risk of transitional cell carcinoma of the urinary tract | |
| P478 | volume | 26 |
| Q36640085 | Aggressive muscle-invasive bladder cancer with sarcomatoid differentiation in a 10-year-old girl: A case report |
| Q35923892 | Bibliometric analysis on retinoblastoma literatures in PubMed during 1929 to 2010. |
| Q28585505 | Constitutional and occupational risk factors associated with bladder cancer |
| Q34877480 | DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. |
| Q34303750 | Differences in the cancer burden among foreign-born and US-born Arab Americans living in metropolitan Detroit |
| Q55109636 | Eine kritische Betrachtung der globalen Forschungsaktivität zum Thema Harnblasenkrebs |
| Q35288237 | European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene |
| Q34273627 | Exploration of the postponing mechanism that delays carcinoma onset |
| Q40904359 | Familial urothelial cell carcinoma of the bladder with autosomal dominant inheritance and late onset phenotype |
| Q55109644 | Harnblasenkrebs |
| Q50905629 | Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families. |
| Q92855835 | Integrative Analysis of Genomic and Clinical Data Reveals Intrinsic Characteristics of Bladder Urothelial Carcinoma Progression |
| Q38191940 | Muscle-invasive bladder cancer in a young adult: a case report and a review of the literature |
| Q41284021 | Rare but Lethal Disease of Childhood: Metastatic, Muscle Invasive Bladder Cancer |
| Q37795340 | Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults |
| Q37623193 | Urinary tract cancers: An overview for general practice |
| Q41196925 | Urothelial carcinoma of the urinary bladder in pediatric patients: a long-term follow-up. |
Search more.